Business Wire Feed

After an Autism Diagnosis: Expert Guidance from Acorn Health

April 3rd, 2026|

CORAL GABLES, Fla.--(BUSINESS WIRE)--#ABATherapy--April is Autism Acceptance Month, a time focused on awareness, acceptance and advocacy, beginning with World Autism Awareness Day on April 2. For many families, the month brings education and reflection. For more...

Agenus Announces Data from Phase II Study of BOT+BAL in Combination with agent-797 in PD-1 Refractory Gastroesophageal Cancer to be Presented at AACR 2026

April 3rd, 2026|

Study highlights novel multi-mechanistic immunotherapy combination in checkpoint-refractory disease Data expected to inform immune modulation, treatment sequencing, and durability of response across hard-to-treat tumors LEXINGTON, Mass.--(BUSINESS WIRE)--$AGEN #AACR2026--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology more...

Innate Pharma to Participate in the Kempen Life Sciences Conference

April 3rd, 2026|

MARSEILLE, France--(BUSINESS WIRE)--#Biotech--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that members of its executive team will participate more...

Vedanta Biosciences Announces the Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection Will Continue as Planned Following Protocol-Specified Interim Analysis

April 2nd, 2026|

Independent Data Monitoring Committee Recommendation was Based on Review of Safety and Efficacy; Enrollment Expected to Complete in 2H 2026CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedanta Biosciences, a late clinical-stage biopharmaceutical company developing microbiome-based oral therapies for gastrointestinal diseases, more...

SV Health Investors Acquires EpiVax

April 2nd, 2026|

BOSTON--(BUSINESS WIRE)--SV Health Investors (“SVHI”), a healthcare and life sciences focused private investment firm, announced today the acquisition of EpiVax, Inc. Headquartered in Providence, RI, EpiVax is a leading bioanalytical CRO specializing in immunogenicity risk more...

Unprecedented Early-Stage Cancer Detection Presented at AACR 2026

April 2nd, 2026|

Dxcover Highlights Liquid Biopsy Platform Performance in Multiple SettingsGLASGOW, Scotland--(BUSINESS WIRE)--Dxcover, a global leader in AI-enabled technologies, today announced the presentation of multiple studies at the American Association for Cancer Research (AACR) Annual Meeting taking more...

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.